Group One Trading
UBX

Group One Trading’s Unity Biotechnology UBX Stock Holding History

Group One Trading’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,484
Closed -$3.98K – 9192
2025
Q2 		$3.98K Sell
10,484
-18,141
-63% -$15.5K ﹤0.01% 7186
2025
Q1 		$29.8K Buy
+28,625
New +$51.7K ﹤0.01% 5543
2023
Q2 		– Sell
-290
Closed -$766 – 8240
2023
Q1 		$473 Buy
+290
New +$1.16K ﹤0.01% 6914
2022
Q4 		– Sell
-969
Closed -$2.81K – 8123
2022
Q3 		$4K Sell
969
-3,607
-79% -$22.7K ﹤0.01% 6957
2022
Q2 		$26K Sell
4,576
-610
-12% -$5.09K ﹤0.01% 6096
2022
Q1 		$58K Buy
5,186
+1,575
+44% +$17.7K ﹤0.01% 5984
2021
Q4 		$53K Buy
3,611
+3,377
+1,443% +$73.8K ﹤0.01% 6292
2021
Q3 		$7K Sell
234
-248
-51% -$8.75K ﹤0.01% 7649
2021
Q2 		$22K Buy
+482
New +$23.2K ﹤0.01% 7133
2020
Q4 		– Sell
-5,444
Closed -$262K – 7027
2020
Q3 		$188K Buy
5,444
+5,425
+28,553% +$344K ﹤0.01% 3700
2020
Q2 		$2K Buy
+19
New +$1.41K ﹤0.01% 5580
2019
Q3 		– Sell
-110
Closed -$10K – 5573
2019
Q2 		$10K Buy
110
+10
+10% +$851 ﹤0.01% 4425
2019
Q1 		$8K Buy
+100
New +$11.3K ﹤0.01% 4344

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Group One Trading's UBX Position: Q3 2025 in Review

Group One Trading sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 10,484 shares — an estimated $3.98K sold.

Group One Trading first reported a position in UBX in Q1 2019 and held it in 13 quarters. The position peaked at $188K in Q3 2020. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Group One Trading reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 10,484 Unity Biotechnology shares in Q3 2025, an estimated $3.98K.
  • Group One Trading first reported a position in Unity Biotechnology in Q1 2019 and held it in 13 quarters.
  • Group One Trading's Unity Biotechnology position peaked at $188K in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.